2017
Reply to: It Is Time to Look for New Treatments for Posttraumatic Stress Disorder: Can Sympathetic System Modulation Be an Answer?
Krystal JH, Davis LL, Neylan TC, Raskind M, Schnurr PP, Stein MB, Vessicchio J, Shiner B, Gleason TC, Huang GD. Reply to: It Is Time to Look for New Treatments for Posttraumatic Stress Disorder: Can Sympathetic System Modulation Be an Answer? Biological Psychiatry 2017, 84: e19-e20. PMID: 29132654, DOI: 10.1016/j.biopsych.2017.09.031.Peer-Reviewed Original ResearchIt Is Time to Address the Crisis in the Pharmacotherapy of Posttraumatic Stress Disorder: A Consensus Statement of the PTSD Psychopharmacology Working Group
Krystal JH, Davis LL, Neylan TC, Raskind M, Schnurr PP, Stein MB, Vessicchio J, Shiner B, Gleason TD, Huang GD. It Is Time to Address the Crisis in the Pharmacotherapy of Posttraumatic Stress Disorder: A Consensus Statement of the PTSD Psychopharmacology Working Group. Biological Psychiatry 2017, 82: e51-e59. PMID: 28454621, DOI: 10.1016/j.biopsych.2017.03.007.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsClinical Trials as TopicHumansPsychopharmacologyPsychotropic DrugsStress Disorders, Post-Traumatic
2007
Psychiatric safety of ketamine in psychopharmacology research
Perry EB, Cramer JA, Cho HS, Petrakis IL, Karper LP, Genovese A, O’Donnell E, Krystal JH, D’Souza D. Psychiatric safety of ketamine in psychopharmacology research. Psychopharmacology 2007, 192: 253-260. PMID: 17458544, DOI: 10.1007/s00213-007-0706-2.Peer-Reviewed Original ResearchConceptsSubanesthetic dosesHealthy human subjectsKetamine administrationClinical research programHuman subjectsTest sessionsPsychotic spectrum disordersPsychiatric safetyResidual sequelaePlacebo infusionIntravenous infusionKetamine effectsPsychopharmacology studiesResultsFour hundredAdverse reactionsObjectiveTo reportHealthy subjectsStudy participationClinical investigationHealthy humansSide effectsKetamineInfusionDosesAdministrationPediatric psychopharmacology: mood, anxiety and disruptive behavior/pervasive developmental disorders
McDougle CJ, Krystal JH. Pediatric psychopharmacology: mood, anxiety and disruptive behavior/pervasive developmental disorders. Psychopharmacology 2007, 191: 1-3. PMID: 17476481, DOI: 10.1007/s00213-007-0720-4.Peer-Reviewed Original Research
2003
A time of promise, a time of promises: ethical issues in advancing psychopharmacological research
Roberts LW, Krystal J. A time of promise, a time of promises: ethical issues in advancing psychopharmacological research. Psychopharmacology 2003, 171: 1-5. PMID: 14615879, DOI: 10.1007/s00213-003-1704-7.Peer-Reviewed Original Research